Market Overview

UPDATE: Abbott Q1 Earnings Reflect AbbVie Separation

Related ABT
Markets Sell-Off After Malaysian Airline Crash In Ukraine
UPDATE: Morgan Stanley Reiterates On Abbott Laboratories As Growth and Margins Are Set To Continue
Will Congress Scuttle the AbbVie-Shire Merger? (Fox Business)

Abbott Laboratories (NYSE: ABT) reported a 56% drop in its first-quarter earnings.

Abbott's quarterly profit fell to $544 million, or $0.34 per share, from $1.24 billion, or $0.78 per share, in the year-ago period. Excluding one-time items, its adjusted earnings from continuing operations rose to $0.42 from $0.40 per share.

Note that Q1 2012 included former proprietary pharmaceuticals business, AbbVie (NYSE: ABBV), from which Abbott Laboratories separated from on January 1, 2013.

Its net sales surged 1.8% to $5.38 billion. Abbott in January expected earnings of $0.40 to $0.42 per share.

Its operating margin widened to 11.4% from 9.7%.

Abbott shares dropped 1.10% to $36.00 in pre-market trading.

Posted-In: profitEarnings News

 

Most Popular

Related Articles (ABT + ABBV)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free